Press release
Irritable Bowel Syndrome with Constipation (IBS-C) Drug Market Is Likely to Experience a Tremendous Growth by 2029
The global irritable bowel syndrome with constipation (IBS-C) drug market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to boost the market include the rise in the geriatric population, increase in the prevalence of gastrointestinal diseases such as constipation, the surge in level of stress, and unhealthy diet. Moreover, some other factors that are expected to fuel the market growth include an increase in awareness programs regarding the treatment and management of IBS and a surge in inclination toward IBS products that enhance therapeutic outcomes. Furthermore, the untapped potential opportunity across developing economies presents lucrative opportunities for the growth of the market during the forecast period.Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that affects the large intestine. Signs & symptoms include abdominal pain, bloating, gas, cramping, and constipation or diarrhea. There are three types of irritable bowel syndrome such as IBS with diarrhea (IBS-D), IBS with constipation (IBS-C), and Mixed IBS. Treatment of irritable bowel syndrome consists of stress relief, change in diet, proper medicines, and counseling. Medications available for the treatment of irritable bowel syndrome include rifaximin, eluxadoline, lubiprostone, linaclotide, and others. Furthermore, antispasmodics are also used for the treatment of irritable bowel syndrome, which includes dicyclomine, peppermint oil, and hyoscyamine. In addition, an increase in the prevalence of gastrointestinal diseases such as constipation and diarrhea due to changes in lifestyles, an increase in the geriatric population, a surge in uptake of drugs such as linaclotide and lubiprostone, and a rise in patient awareness toward the treatment of irritable bowel syndrome are some other factors that will propel the growth of the global IBS-C drug market during the forecast period.
To Request a Sample of our Report on Irritable Bowel Syndrome with Constipation (IBS-C) Drug Market: https://www.omrglobal.com/request-sample/ibs-c-drug-market
Market Coverage
• The market number available for - 2021-2029
• Base year- 2021
• Forecast period- 2023-2029
Segment Covered-
· By Drug Type
· By Prescription Type
Regions covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape: Catalent Pharma Solutions, Inc., AstraZeneca plc, and Abbott Laboratories, among others.
IBS-C Drug Market Report by Segment
By Drug Type
• Lubiprostone
• Linaclotide
• Stimulant Laxatives
• Osmotic Laxatives
• Others
By Prescription Type
• Prescription Drugs
• Over-the-Counter Drugs
A full Report of Irritable Bowel Syndrome with Constipation (IBS-C) Drug Market is Available @ https://www.omrglobal.com/industry-reports/ibs-c-drug-market
IBS-C Drug Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
https://www.asiatimeskorea.com/news/2029%eb%85%84%ea%b9%8c%ec%a7%80-%eb%86%80%eb%9d%bc%ec%9a%b4-%ec%84%b1%ec%9e%a5%ec%9d%84-%eb%aa%a9%ea%b2%a9%ed%95%98%eb%8a%94-%ea%b5%90%ed%86%b5-%ec%8b%a0%ed%98%b8-%ec%bc%80%ec%9d%b4%eb%b8%94/359387/
https://monblogapple.com/2023/02/24/le-marche-des-revendeurs-de-vehicules-devrait-augmenter-a-un-tcac-stable-au-cours-de-la-periode-de-prevision-2023-a-2029/
https://www.diario-ya.com/regionales/%e5%88%b0-2029-%e5%b9%b4%e4%ba%9e%e5%a4%aa%e9%9b%bb%e5%ad%90%e5%82%b3%e6%84%9f%e5%99%a8%e5%b8%82%e5%a0%b4%e5%b0%87%e5%8a%a0%e9%80%9f%e5%a2%9e%e9%95%b7/449710/
https://revistaeconomiasocial.com/2023/02/24/es-probable-que-el-mercado-europeo-de-sensores-electronicos-experimente-un-enorme-crecimiento-para-2029/
https://sportmsr.com/%d9%85%d9%86-%d8%a7%d9%84%d9%85%d8%aa%d9%88%d9%82%d8%b9-%d8%a3%d9%86-%d9%8a%d8%b1%d8%aa%d9%81%d8%b9-%d8%b3%d9%88%d9%82-%d8%a3%d8%ac%d9%87%d8%b2%d8%a9-%d8%a7%d9%84%d8%a7%d8%b3%d8%aa%d8%b4%d8%b9-13/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Irritable Bowel Syndrome with Constipation (IBS-C) Drug Market Is Likely to Experience a Tremendous Growth by 2029 here
News-ID: 2949360 • Views: …
More Releases from Orion Market Research

Organic Corn Market Size Analysis, Competitive Insights, Leading Players and Gro …
In 2023, the global organic corn market was valued at approximately USD 1.25 billion, and it is projected to reach around USD 1.49 billion by 2033, growing at a compound annual growth rate (CAGR) of about 2.3% from 2024 to 2033.
Organic Corn Market Overview
The organic corn market is steadily expanding due to increasing consumer demand for natural, non-GMO, and sustainably produced food products. Organic corn is used in a variety…

Microcars Market Size Future Scope, Demands and Projected Industry Growths to 20 …
In 2023, the global microcars market was valued at approximately USD 9.7 billion, and it is expected to grow to around USD 18.7 billion by 2033, corresponding to a compound annual growth rate (CAGR) of about 6.8% from 2023 to 2033.
Microcars Market Overview
Microcars-compact, fuel-efficient vehicles designed for urban mobility-are gaining traction amid growing congestion, rising fuel costs, and a push for eco-friendly transportation. These vehicles, which include electric, hybrid,…

OSAT Market Size Future Scope, Demands and Projected Industry Growths to 2033
In 2023, the global OSAT market was valued at approximately USD 38.68 billion, and it is anticipated to grow to around USD 94.87 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9.9% from 2028 to 2033.
OSAT Market Overview
The OSAT market plays a pivotal role in the semiconductor value chain by providing outsourced assembly, packaging, and testing services that bridge the gap between chip fabrication and final…

Thermo ventilators Market Rising Demand and Growth Forecast Through 2033
In 2023, the global thermo ventilators market was worth approximately USD 3.5 billion, and it is expected to reach around USD 6.2 billion by 2032, with a CAGR of about 6.7% from 2024 to 2032.
Thermo ventilators Market Overview
The thermo ventilators market is expanding swiftly, driven by rising demand for energy-efficient ventilation systems that enhance indoor air quality while minimizing energy loss. Increasing emphasis on green building standards, government energy regulations,…
More Releases for IBS
Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs.
👉 Download our latest market insights:…
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR…
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA…
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide.
A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L…
HaCon and IBS combine expertise in railway operation
Hanover (2010-07-06). Two Hanoverian companies now combine their expertise in questions of railway operations: With effect from 1 July 2010, the HaCon Ingenieurgesellschaft mbH, took over the engineering firm for railway operating systems (Ingenieurbüro für Bahnbetriebssysteme GmbH – IBS). This way HaCon expanded its services to include the areas operation simulation, vehicle and personnel planning and construction operations planning.
This also includes consulting services concerning railway systems issues, such as travel…
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011.
The new bulkers, each with a capacity of 176,000 dwt, will be equipped…